3D Medicines, Inc. 1244

Wall Street expects no quarterly revenue and a GAAP loss of $0.04 per share, narrowing from $0.05 previously.

Vontobel cut its holding by 16% but retained SLS shares worth $2.17 million.

New York State Common Retirement Fund boosted its holding by 70%, while Commonwealth and Axxcess each raised stakes by about 17%.

Sellas estimated cash and cash equivalents of $138.3 million as of June 30.

Sellas is seeking about $13 million in disputed GPS milestone payments related to Phase 3 development.

As inflation pressures rise amid higher energy costs, Asian markets are navigating a complex economic landscape. Despite these challenges, the potential for growth remains, particularly in the realm of penny stocks. Although the term 'penny stock' may seem outdated, it continues to represent smaller or newer companies that can offer significant value when backed by strong financials.

As global markets continue to show resilience, with U.S. stocks reaching record highs and optimism surrounding artificial intelligence bolstering sentiment, investors are keenly observing opportunities across various sectors. Amid this backdrop, penny stocks remain a compelling area for exploration due to their potential for significant returns when backed by strong financials. Despite the term's somewhat outdated nature, these smaller or newer companies can offer unique value propositions...